Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Dabigatran etexilate

Dabigatran etexilate

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Dabigatran etexilate

36 trials tracked of Dabigatran etexilate: 11 in phase 3 or 4 and 1 with published results. The most-cited published study has 15 citations.

36Trials tracked
11Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 3 Phase 3 8 Phase 2 5 Phase 1 18 Other / NA 2
  1. Phase 4 Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation Completed · 15 cited
  2. Phase 4 Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism Completed
  3. Phase 4 Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate Completed
  4. Phase 3 A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT) Completed
  5. Phase 3 Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE) Completed
  6. Phase 3 Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) Completed
Show 30 more trials
  1. Phase 3 Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty Completed
  2. Phase 3 Safety of Dabigatran Etexilate in Blood Clot Prevention in Children Completed
  3. Phase 3 Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE) Completed
  4. Phase 3 Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery Completed
  5. Phase 3 RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery Completed
  6. Phase 2 RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome Completed
  7. Phase 2 Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age Completed
  8. Phase 2 A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin Completed
  9. Phase 2 Safety and Tolerability of Dabigatran Etexilate in Adolescents Completed
  10. Phase 2 A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery. Completed
  11. Phase 1 Bioequivalence of Two Different Capsule Types of Dabigatran Completed
  12. Phase 1 Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor Completed
  13. Phase 1 Effect of Tepotinib on the PK of the P-gp Substrate Dabigatran Etexilate Completed
  14. Phase 1 Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan Completed
  15. Phase 1 Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease. Completed
  16. Phase 1 A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood Completed
  17. Phase 1 A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood Completed
  18. Phase 1 Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant Completed
  19. Phase 1 Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy Volunteers Completed
  20. Phase 1 Bioequivalence of Tablet Formulation of Dabigatran Etexilate Compared to Commercial Capsule Formulation Following Oral Administration in Healthy Male Subjects Completed
  21. Phase 1 A Study of Lasmiditan in Healthy Volunteers Completed
  22. Phase 1 Study to Investigate the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Idarucizumab in Chinese Healthy Male and Female Volunteers Who Had Taken Dabigatran Etexilate and Whose Plasma Concentrations of Dabigatran Were at or Close to Steady State Completed
  23. Phase 1 Drug Interaction Study With Dabigatran Etexilate and Dronedarone in Healthy Subjects Completed
  24. Phase 1 Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran Completed
  25. Phase 1 A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants Completed
  26. Phase 1 A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy Adults Completed
  27. Phase 1 Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During Haemodialysis Completed
  28. Phase 1 A Drug-drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants Completed
  29. N/A Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF) Completed
  30. N/A Validation of Predictors of OAC Initiation Using EMR Data Completed

Showing the 36 most-cited and recently-updated of 36 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.